Orexigen Therapeutics, Inc. news

   Watch this stock
Showing stories 1 - 10 of about 74   

Articles published

OREX 5.08 -0.11 (-2.12%)
price chart
Stocks Alert: Genworth Financial Inc (NYSE:GNW), Orexigen Therapeutics, Inc ...
Lakeway, NY - (MARKET NEWS CALL) - 7/30/2014� Specialpennystockalert.com, an investment community with a special focus on updating investors with recent news on the U.S.
Related articles »  
Orexigen receives 180 LOI from EMA regarding NB32 submission (OREX)
The European Medicines Agency sends a 180 List of Outstanding Issues to Orexigen Therapeutics (OREX -2.7%) regarding its Marketing Authorization Application (MAA) for NB32 (naltrexone/bupropion), its investigational drug candidate for weight loss ...
Outstanding issues delay Orexigen's naltrexone/bupropion drug approval ...  Healio
Related articles »  
Perilous Reversal Watch: Orexigen Therapeutics (OREX)
Orexigen Therapeutics, Inc., a biopharmaceutical company, focuses on the development of pharmaceutical product candidates for the treatment of obesity.
Trader's Buzzers � Orexigen Therapeutics, (NASDAQ:OREX), TRI Pointe ...  Techsonian (press release)
Related articles »  
Orexigen Therapeutics, Inc. (OREX): New Analyst Report from Zacks Equity ...
We are initiating coverage on Orexigen with a Neutral recommendation. Orexigen suffered a loss of $0.23 per share in the first quarter of 2014, wider than the Zacks Consensus Estimate of a loss of $0.20 and the year-ago loss of $0.21.
Trade-Ideas: Orexigen Therapeutics (OREX) Is Today's "Dead Cat Bounce" Stock
Orexigen Therapeutics, Inc., a biopharmaceutical company, focuses on the development of pharmaceutical product candidates for the treatment of obesity.
Short Interest in Orexigen Therapeutics Decreases By 5.9% (OREX)  Ticker Report
Related articles »  
Momentum Stocks in Focus - Orexigen Therapeutics, Inc. (NASDAQ:OREX ...
Orexigen Therapeutics, Inc. (NASDAQ:OREX) ended its recent business day with the loss of -1.86% and closed at the price of $5.29 after opening at $5.41.
Related articles »  
Traders Recap � Polycom Inc (PLCM), Orexigen Therapeutics, Inc. (OREX ...
Orexigen Therapeutics, Inc. (NASDAQ:OREX), a biopharmaceutical company, focuses on the development of pharmaceutical product candidates for the treatment of obesity.
Related articles »  
Stocks in the News - Tri Pointe Homes Inc (TPH), Orexigen Therapeutics, Inc ...
Orexigen Therapeutics, Inc. (NASDAQ:OREX) publicized that management will present a company overview at the Wells Fargo Securities 2014 Healthcare Conference in Boston.
Related articles »  
Investor's Alert - Glu Mobile Inc.(NASDAQ:GLUU), Orexigen Therapeutics, Inc ...
Orexigen Therapeutics, Inc.(NASDAQ:OREX) was at $5.47, showing a -2.69% decrease. Around 3 million shares have been traded, versus an-average trading volume of 4.44M shares.
Special News Alert: Himax Technologies, Inc. (ADR) (NASDAQ:HIMX), Vringo ...  Market News Call
Related articles »  
Hot Stock's Alert - Orexigen Therapeutics, Inc. (OREX), Questcor ...
Orexigen Therapeutics, Inc.(NASDAQ:OREX) gaining3.30% and closed at $5.63 on a traded volume of 2.12 million shares, in comparison to 4.32 million shares of average trading volume.